Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease
Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease
Recruiting · NCT05924425 · Registry updated 2026-06-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease | Alzheimer disease, Dyssomnias, Sleep Disorders, Intrinsic, Sleeplessness, brain disorder, central nervous system disorder, cognitive disorder, dementia, insomnia, nervous system disorder, neurodegenerative disease, psychiatric disorder, sleep-wake disorder, tauopathy | Recruiting | Phase 4 | 2026-06-25 | NCT05924425 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Idorsia Pharmaceuticals Ltd. | 11 |
| University Hospital, Montpellier | 211 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University Hospital, Montpellier | Montpellier | France | 8 |